Late Adverse Effects after Treatment for Childhood Acute Leukemia Article Swipe
Jelena Roganović
,
Riccardo Haupt
,
Edit Bárdi
,
Lars Hjorth
,
Gisela Michel
,
Vesna Pavasovic
,
Katrin Scheinemann
,
Helena JH van der Pal
,
Lorna Zadravec Zaletel
,
Ana E. Amariutei
,
Roderick Skinner
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.5644/ama2006-124.438
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.5644/ama2006-124.438
The aim of this review is to raise awareness and knowledge among healthcare professionals and policymakers about late adverse effects in survivors of childhood leukemia. With contemporary treatment, over 90% of children with acute lymphoblastic leukemia (ALL) and over 60% with acute myeloid leukemia (AML) are cured. Large cohort studies demonstrate that 20% of ALL and most AML survivors have at least one chronic health condition by 20-25 years after diagnosis. These are life-changing or threatening in some survivors and contribute to increased premature mortality. We describe the frequency, causes, clinical features, and natural history of the most frequent and severe late adverse effects in childhood leukemia survivors, including subsequent malignant neoplasms, metabolic toxicity, gonadotoxicity and impaired fertility, endocrinopathy and growth disturbances, bone toxicity, central and peripheral neurotoxicity, cardiotoxicity, psychosocial late effects, accelerated ageing and late mortality. The wide range of late effects in survivors of haemopoietic stem cell transplant is highlighted. Recent developments informing the approach to long-term survivorship care are discussed, including electronic personalized patient-specific treatment summaries and care plans such as the Survivor Passport (SurPass), surveillance guidelines and models of care. The importance of ongoing vigilance is stressed given the increasing use of novel targeted drugs with limited experience of long-term outcomes. Conclusion. It is vital to raise awareness of the existence and severity of late effects of childhood leukemia therapy among parents, patients, health professionals, and policymakers. Structured long-term surveillance recommendations are necessary to standardize follow-up care.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.5644/ama2006-124.438
- OA Status
- diamond
- Cited By
- 7
- References
- 83
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4394882955
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4394882955Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.5644/ama2006-124.438Digital Object Identifier
- Title
-
Late Adverse Effects after Treatment for Childhood Acute LeukemiaWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-04-15Full publication date if available
- Authors
-
Jelena Roganović, Riccardo Haupt, Edit Bárdi, Lars Hjorth, Gisela Michel, Vesna Pavasovic, Katrin Scheinemann, Helena JH van der Pal, Lorna Zadravec Zaletel, Ana E. Amariutei, Roderick SkinnerList of authors in order
- Landing page
-
https://doi.org/10.5644/ama2006-124.438Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
diamondOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.5644/ama2006-124.438Direct OA link when available
- Concepts
-
Medicine, Childhood leukemia, Psychosocial, Survivorship curve, Myeloid leukemia, Adverse effect, Cardiotoxicity, Intensive care medicine, Pediatrics, Leukemia, Psychiatry, Cancer, Internal medicine, Toxicity, Lymphoblastic LeukemiaTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
7Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 7Per-year citation counts (last 5 years)
- References (count)
-
83Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4394882955 |
|---|---|
| doi | https://doi.org/10.5644/ama2006-124.438 |
| ids.doi | https://doi.org/10.5644/ama2006-124.438 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/38984700 |
| ids.openalex | https://openalex.org/W4394882955 |
| fwci | 33.10488284 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | Q000628 |
| mesh[1].descriptor_ui | D015470 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | therapy |
| mesh[1].descriptor_name | Leukemia, Myeloid, Acute |
| mesh[2].qualifier_ui | Q000188 |
| mesh[2].descriptor_ui | D015470 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | drug therapy |
| mesh[2].descriptor_name | Leukemia, Myeloid, Acute |
| mesh[3].qualifier_ui | Q000188 |
| mesh[3].descriptor_ui | D054198 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | drug therapy |
| mesh[3].descriptor_name | Precursor Cell Lymphoblastic Leukemia-Lymphoma |
| mesh[4].qualifier_ui | Q000628 |
| mesh[4].descriptor_ui | D054198 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | therapy |
| mesh[4].descriptor_name | Precursor Cell Lymphoblastic Leukemia-Lymphoma |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D000073116 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Cancer Survivors |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D002648 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Child |
| mesh[7].qualifier_ui | Q000009 |
| mesh[7].descriptor_ui | D018380 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | adverse effects |
| mesh[7].descriptor_name | Hematopoietic Stem Cell Transplantation |
| mesh[8].qualifier_ui | Q000139 |
| mesh[8].descriptor_ui | D000069451 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | chemically induced |
| mesh[8].descriptor_name | Long Term Adverse Effects |
| mesh[9].qualifier_ui | Q000009 |
| mesh[9].descriptor_ui | D000970 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | adverse effects |
| mesh[9].descriptor_name | Antineoplastic Agents |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D006801 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Humans |
| mesh[11].qualifier_ui | Q000628 |
| mesh[11].descriptor_ui | D015470 |
| mesh[11].is_major_topic | True |
| mesh[11].qualifier_name | therapy |
| mesh[11].descriptor_name | Leukemia, Myeloid, Acute |
| mesh[12].qualifier_ui | Q000188 |
| mesh[12].descriptor_ui | D015470 |
| mesh[12].is_major_topic | True |
| mesh[12].qualifier_name | drug therapy |
| mesh[12].descriptor_name | Leukemia, Myeloid, Acute |
| mesh[13].qualifier_ui | Q000188 |
| mesh[13].descriptor_ui | D054198 |
| mesh[13].is_major_topic | True |
| mesh[13].qualifier_name | drug therapy |
| mesh[13].descriptor_name | Precursor Cell Lymphoblastic Leukemia-Lymphoma |
| mesh[14].qualifier_ui | Q000628 |
| mesh[14].descriptor_ui | D054198 |
| mesh[14].is_major_topic | True |
| mesh[14].qualifier_name | therapy |
| mesh[14].descriptor_name | Precursor Cell Lymphoblastic Leukemia-Lymphoma |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D000073116 |
| mesh[15].is_major_topic | True |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | Cancer Survivors |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D002648 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Child |
| mesh[17].qualifier_ui | Q000009 |
| mesh[17].descriptor_ui | D018380 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | adverse effects |
| mesh[17].descriptor_name | Hematopoietic Stem Cell Transplantation |
| mesh[18].qualifier_ui | Q000139 |
| mesh[18].descriptor_ui | D000069451 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | chemically induced |
| mesh[18].descriptor_name | Long Term Adverse Effects |
| mesh[19].qualifier_ui | Q000009 |
| mesh[19].descriptor_ui | D000970 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | adverse effects |
| mesh[19].descriptor_name | Antineoplastic Agents |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D006801 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Humans |
| mesh[21].qualifier_ui | Q000628 |
| mesh[21].descriptor_ui | D015470 |
| mesh[21].is_major_topic | True |
| mesh[21].qualifier_name | therapy |
| mesh[21].descriptor_name | Leukemia, Myeloid, Acute |
| mesh[22].qualifier_ui | Q000188 |
| mesh[22].descriptor_ui | D015470 |
| mesh[22].is_major_topic | True |
| mesh[22].qualifier_name | drug therapy |
| mesh[22].descriptor_name | Leukemia, Myeloid, Acute |
| mesh[23].qualifier_ui | Q000188 |
| mesh[23].descriptor_ui | D054198 |
| mesh[23].is_major_topic | True |
| mesh[23].qualifier_name | drug therapy |
| mesh[23].descriptor_name | Precursor Cell Lymphoblastic Leukemia-Lymphoma |
| mesh[24].qualifier_ui | Q000628 |
| mesh[24].descriptor_ui | D054198 |
| mesh[24].is_major_topic | True |
| mesh[24].qualifier_name | therapy |
| mesh[24].descriptor_name | Precursor Cell Lymphoblastic Leukemia-Lymphoma |
| mesh[25].qualifier_ui | |
| mesh[25].descriptor_ui | D000073116 |
| mesh[25].is_major_topic | True |
| mesh[25].qualifier_name | |
| mesh[25].descriptor_name | Cancer Survivors |
| mesh[26].qualifier_ui | |
| mesh[26].descriptor_ui | D002648 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | |
| mesh[26].descriptor_name | Child |
| mesh[27].qualifier_ui | Q000009 |
| mesh[27].descriptor_ui | D018380 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | adverse effects |
| mesh[27].descriptor_name | Hematopoietic Stem Cell Transplantation |
| mesh[28].qualifier_ui | Q000139 |
| mesh[28].descriptor_ui | D000069451 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | chemically induced |
| mesh[28].descriptor_name | Long Term Adverse Effects |
| mesh[29].qualifier_ui | Q000009 |
| mesh[29].descriptor_ui | D000970 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | adverse effects |
| mesh[29].descriptor_name | Antineoplastic Agents |
| mesh[30].qualifier_ui | |
| mesh[30].descriptor_ui | D006801 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | |
| mesh[30].descriptor_name | Humans |
| mesh[31].qualifier_ui | Q000628 |
| mesh[31].descriptor_ui | D015470 |
| mesh[31].is_major_topic | True |
| mesh[31].qualifier_name | therapy |
| mesh[31].descriptor_name | Leukemia, Myeloid, Acute |
| mesh[32].qualifier_ui | Q000188 |
| mesh[32].descriptor_ui | D015470 |
| mesh[32].is_major_topic | True |
| mesh[32].qualifier_name | drug therapy |
| mesh[32].descriptor_name | Leukemia, Myeloid, Acute |
| mesh[33].qualifier_ui | Q000188 |
| mesh[33].descriptor_ui | D054198 |
| mesh[33].is_major_topic | True |
| mesh[33].qualifier_name | drug therapy |
| mesh[33].descriptor_name | Precursor Cell Lymphoblastic Leukemia-Lymphoma |
| mesh[34].qualifier_ui | Q000628 |
| mesh[34].descriptor_ui | D054198 |
| mesh[34].is_major_topic | True |
| mesh[34].qualifier_name | therapy |
| mesh[34].descriptor_name | Precursor Cell Lymphoblastic Leukemia-Lymphoma |
| mesh[35].qualifier_ui | |
| mesh[35].descriptor_ui | D000073116 |
| mesh[35].is_major_topic | True |
| mesh[35].qualifier_name | |
| mesh[35].descriptor_name | Cancer Survivors |
| mesh[36].qualifier_ui | |
| mesh[36].descriptor_ui | D002648 |
| mesh[36].is_major_topic | False |
| mesh[36].qualifier_name | |
| mesh[36].descriptor_name | Child |
| mesh[37].qualifier_ui | Q000009 |
| mesh[37].descriptor_ui | D018380 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | adverse effects |
| mesh[37].descriptor_name | Hematopoietic Stem Cell Transplantation |
| mesh[38].qualifier_ui | Q000139 |
| mesh[38].descriptor_ui | D000069451 |
| mesh[38].is_major_topic | False |
| mesh[38].qualifier_name | chemically induced |
| mesh[38].descriptor_name | Long Term Adverse Effects |
| mesh[39].qualifier_ui | Q000009 |
| mesh[39].descriptor_ui | D000970 |
| mesh[39].is_major_topic | False |
| mesh[39].qualifier_name | adverse effects |
| mesh[39].descriptor_name | Antineoplastic Agents |
| type | article |
| title | Late Adverse Effects after Treatment for Childhood Acute Leukemia |
| biblio.issue | 1 |
| biblio.volume | 53 |
| biblio.last_page | 80 |
| biblio.first_page | 59 |
| topics[0].id | https://openalex.org/T11141 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9998999834060669 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2735 |
| topics[0].subfield.display_name | Pediatrics, Perinatology and Child Health |
| topics[0].display_name | Childhood Cancer Survivors' Quality of Life |
| topics[1].id | https://openalex.org/T10950 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9997000098228455 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2739 |
| topics[1].subfield.display_name | Public Health, Environmental and Occupational Health |
| topics[1].display_name | Acute Lymphoblastic Leukemia research |
| topics[2].id | https://openalex.org/T10309 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9822999835014343 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2720 |
| topics[2].subfield.display_name | Hematology |
| topics[2].display_name | Acute Myeloid Leukemia Research |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.8275690674781799 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2779401946 |
| concepts[1].level | 4 |
| concepts[1].score | 0.7060701251029968 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q5097982 |
| concepts[1].display_name | Childhood leukemia |
| concepts[2].id | https://openalex.org/C150966472 |
| concepts[2].level | 2 |
| concepts[2].score | 0.6682864427566528 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q3410145 |
| concepts[2].display_name | Psychosocial |
| concepts[3].id | https://openalex.org/C172400760 |
| concepts[3].level | 3 |
| concepts[3].score | 0.639911413192749 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q332796 |
| concepts[3].display_name | Survivorship curve |
| concepts[4].id | https://openalex.org/C2778729363 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5864731073379517 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q11688946 |
| concepts[4].display_name | Myeloid leukemia |
| concepts[5].id | https://openalex.org/C197934379 |
| concepts[5].level | 2 |
| concepts[5].score | 0.5724287033081055 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q2047938 |
| concepts[5].display_name | Adverse effect |
| concepts[6].id | https://openalex.org/C2778233292 |
| concepts[6].level | 3 |
| concepts[6].score | 0.5290706753730774 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q2118956 |
| concepts[6].display_name | Cardiotoxicity |
| concepts[7].id | https://openalex.org/C177713679 |
| concepts[7].level | 1 |
| concepts[7].score | 0.5057611465454102 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q679690 |
| concepts[7].display_name | Intensive care medicine |
| concepts[8].id | https://openalex.org/C187212893 |
| concepts[8].level | 1 |
| concepts[8].score | 0.49623018503189087 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q123028 |
| concepts[8].display_name | Pediatrics |
| concepts[9].id | https://openalex.org/C2778461978 |
| concepts[9].level | 2 |
| concepts[9].score | 0.4800071120262146 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q29496 |
| concepts[9].display_name | Leukemia |
| concepts[10].id | https://openalex.org/C118552586 |
| concepts[10].level | 1 |
| concepts[10].score | 0.2854310870170593 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q7867 |
| concepts[10].display_name | Psychiatry |
| concepts[11].id | https://openalex.org/C121608353 |
| concepts[11].level | 2 |
| concepts[11].score | 0.22027885913848877 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[11].display_name | Cancer |
| concepts[12].id | https://openalex.org/C126322002 |
| concepts[12].level | 1 |
| concepts[12].score | 0.21883156895637512 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[12].display_name | Internal medicine |
| concepts[13].id | https://openalex.org/C29730261 |
| concepts[13].level | 2 |
| concepts[13].score | 0.21244513988494873 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q274160 |
| concepts[13].display_name | Toxicity |
| concepts[14].id | https://openalex.org/C2909962599 |
| concepts[14].level | 3 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q180664 |
| concepts[14].display_name | Lymphoblastic Leukemia |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.8275690674781799 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/childhood-leukemia |
| keywords[1].score | 0.7060701251029968 |
| keywords[1].display_name | Childhood leukemia |
| keywords[2].id | https://openalex.org/keywords/psychosocial |
| keywords[2].score | 0.6682864427566528 |
| keywords[2].display_name | Psychosocial |
| keywords[3].id | https://openalex.org/keywords/survivorship-curve |
| keywords[3].score | 0.639911413192749 |
| keywords[3].display_name | Survivorship curve |
| keywords[4].id | https://openalex.org/keywords/myeloid-leukemia |
| keywords[4].score | 0.5864731073379517 |
| keywords[4].display_name | Myeloid leukemia |
| keywords[5].id | https://openalex.org/keywords/adverse-effect |
| keywords[5].score | 0.5724287033081055 |
| keywords[5].display_name | Adverse effect |
| keywords[6].id | https://openalex.org/keywords/cardiotoxicity |
| keywords[6].score | 0.5290706753730774 |
| keywords[6].display_name | Cardiotoxicity |
| keywords[7].id | https://openalex.org/keywords/intensive-care-medicine |
| keywords[7].score | 0.5057611465454102 |
| keywords[7].display_name | Intensive care medicine |
| keywords[8].id | https://openalex.org/keywords/pediatrics |
| keywords[8].score | 0.49623018503189087 |
| keywords[8].display_name | Pediatrics |
| keywords[9].id | https://openalex.org/keywords/leukemia |
| keywords[9].score | 0.4800071120262146 |
| keywords[9].display_name | Leukemia |
| keywords[10].id | https://openalex.org/keywords/psychiatry |
| keywords[10].score | 0.2854310870170593 |
| keywords[10].display_name | Psychiatry |
| keywords[11].id | https://openalex.org/keywords/cancer |
| keywords[11].score | 0.22027885913848877 |
| keywords[11].display_name | Cancer |
| keywords[12].id | https://openalex.org/keywords/internal-medicine |
| keywords[12].score | 0.21883156895637512 |
| keywords[12].display_name | Internal medicine |
| keywords[13].id | https://openalex.org/keywords/toxicity |
| keywords[13].score | 0.21244513988494873 |
| keywords[13].display_name | Toxicity |
| language | en |
| locations[0].id | doi:10.5644/ama2006-124.438 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210201824 |
| locations[0].source.issn | 1840-1848, 1840-2879 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1840-1848 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Acta Medica Academica |
| locations[0].source.host_organization | https://openalex.org/P4310321207 |
| locations[0].source.host_organization_name | Academy of Sciences and Arts of Bosnia and Herzegovina |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310321207 |
| locations[0].source.host_organization_lineage_names | Academy of Sciences and Arts of Bosnia and Herzegovina |
| locations[0].license | cc-by-nc |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Acta Medica Academica |
| locations[0].landing_page_url | https://doi.org/10.5644/ama2006-124.438 |
| locations[1].id | pmid:38984700 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Acta medica academica |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/38984700 |
| locations[2].id | pmh:oai:lup.lub.lu.se:9a4de1c5-b75b-4b59-8129-2493d30b7ffb |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306400536 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | Lund University Publications (Lund University) |
| locations[2].source.host_organization | https://openalex.org/I187531555 |
| locations[2].source.host_organization_name | Lund University |
| locations[2].source.host_organization_lineage | https://openalex.org/I187531555 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | text |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | ISSN: 1840-1848 |
| locations[2].landing_page_url | https://lup.lub.lu.se/record/9a4de1c5-b75b-4b59-8129-2493d30b7ffb |
| locations[3].id | pmh:oai:pubmedcentral.nih.gov:11237916 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S2764455111 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | PubMed Central |
| locations[3].source.host_organization | https://openalex.org/I1299303238 |
| locations[3].source.host_organization_name | National Institutes of Health |
| locations[3].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[3].license | other-oa |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | https://openalex.org/licenses/other-oa |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | Acta Med Acad |
| locations[3].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11237916 |
| locations[4].id | doi:10.5281/zenodo.12750224 |
| locations[4].is_oa | True |
| locations[4].source.id | https://openalex.org/S4306400562 |
| locations[4].source.issn | |
| locations[4].source.type | repository |
| locations[4].source.is_oa | True |
| locations[4].source.issn_l | |
| locations[4].source.is_core | False |
| locations[4].source.is_in_doaj | False |
| locations[4].source.display_name | Zenodo (CERN European Organization for Nuclear Research) |
| locations[4].source.host_organization | https://openalex.org/I67311998 |
| locations[4].source.host_organization_name | European Organization for Nuclear Research |
| locations[4].source.host_organization_lineage | https://openalex.org/I67311998 |
| locations[4].license | cc-by |
| locations[4].pdf_url | |
| locations[4].version | |
| locations[4].raw_type | article-journal |
| locations[4].license_id | https://openalex.org/licenses/cc-by |
| locations[4].is_accepted | False |
| locations[4].is_published | |
| locations[4].raw_source_name | |
| locations[4].landing_page_url | https://doi.org/10.5281/zenodo.12750224 |
| indexed_in | crossref, datacite, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5068684894 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-7960-6069 |
| authorships[0].author.display_name | Jelena Roganović |
| authorships[0].countries | HR |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I154347574, https://openalex.org/I4210137817 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Pediatric Hematology and Oncology, Children's Hospital Zagreb, Zagreb, Croatia; Faculty of Biotechnology and Drug Development, University of Rijeka, Rijeka, Croatia. |
| authorships[0].institutions[0].id | https://openalex.org/I4210137817 |
| authorships[0].institutions[0].ror | https://ror.org/03rmwy138 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210137817 |
| authorships[0].institutions[0].country_code | HR |
| authorships[0].institutions[0].display_name | Children's Hospital Zagreb |
| authorships[0].institutions[1].id | https://openalex.org/I154347574 |
| authorships[0].institutions[1].ror | https://ror.org/05r8dqr10 |
| authorships[0].institutions[1].type | education |
| authorships[0].institutions[1].lineage | https://openalex.org/I154347574 |
| authorships[0].institutions[1].country_code | HR |
| authorships[0].institutions[1].display_name | University of Rijeka |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Jelena Roganovic |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Pediatric Hematology and Oncology, Children's Hospital Zagreb, Zagreb, Croatia; Faculty of Biotechnology and Drug Development, University of Rijeka, Rijeka, Croatia. |
| authorships[1].author.id | https://openalex.org/A5037623587 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-0571-8460 |
| authorships[1].author.display_name | Riccardo Haupt |
| authorships[1].countries | IT |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I2801463291 |
| authorships[1].affiliations[0].raw_affiliation_string | Epidemiology and Biostatistics Unit and DOPO Clinic, IRCCS Istituto Giannina Gaslini, Genova, Italy. |
| authorships[1].institutions[0].id | https://openalex.org/I2801463291 |
| authorships[1].institutions[0].ror | https://ror.org/0424g0k78 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I2801463291, https://openalex.org/I4210153126 |
| authorships[1].institutions[0].country_code | IT |
| authorships[1].institutions[0].display_name | Istituto Giannina Gaslini |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Riccardo Haupt |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Epidemiology and Biostatistics Unit and DOPO Clinic, IRCCS Istituto Giannina Gaslini, Genova, Italy. |
| authorships[2].author.id | https://openalex.org/A5052340947 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-7424-6255 |
| authorships[2].author.display_name | Edit Bárdi |
| authorships[2].countries | AT |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210123554 |
| authorships[2].affiliations[0].raw_affiliation_string | St. Anna Childrens Hospital, Wien; Department of Pediatrics and Adolescent Medicine, Johannes Kepler University Linz, Kepler University Hospital, Linz, Austria. |
| authorships[2].institutions[0].id | https://openalex.org/I4210123554 |
| authorships[2].institutions[0].ror | https://ror.org/02qb3f692 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210123554 |
| authorships[2].institutions[0].country_code | AT |
| authorships[2].institutions[0].display_name | St Anna Children's Hospital |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Edit Bárdi |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | St. Anna Childrens Hospital, Wien; Department of Pediatrics and Adolescent Medicine, Johannes Kepler University Linz, Kepler University Hospital, Linz, Austria. |
| authorships[3].author.id | https://openalex.org/A5057281435 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-8302-7174 |
| authorships[3].author.display_name | Lars Hjorth |
| authorships[3].countries | SE |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I187531555, https://openalex.org/I4210137844 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Pediatrics, Skane University Hospital; Department of Clinical Sciences, Lund University, Lund, Sweden. |
| authorships[3].institutions[0].id | https://openalex.org/I187531555 |
| authorships[3].institutions[0].ror | https://ror.org/012a77v79 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I187531555 |
| authorships[3].institutions[0].country_code | SE |
| authorships[3].institutions[0].display_name | Lund University |
| authorships[3].institutions[1].id | https://openalex.org/I4210137844 |
| authorships[3].institutions[1].ror | https://ror.org/02z31g829 |
| authorships[3].institutions[1].type | healthcare |
| authorships[3].institutions[1].lineage | https://openalex.org/I4210137844 |
| authorships[3].institutions[1].country_code | SE |
| authorships[3].institutions[1].display_name | Skåne University Hospital |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Lars Hjorth |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Pediatrics, Skane University Hospital; Department of Clinical Sciences, Lund University, Lund, Sweden. |
| authorships[4].author.id | https://openalex.org/A5014087930 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-9589-0928 |
| authorships[4].author.display_name | Gisela Michel |
| authorships[4].countries | CH |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I161941770 |
| authorships[4].affiliations[0].raw_affiliation_string | Faculty of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland. |
| authorships[4].institutions[0].id | https://openalex.org/I161941770 |
| authorships[4].institutions[0].ror | https://ror.org/00kgrkn83 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I161941770 |
| authorships[4].institutions[0].country_code | CH |
| authorships[4].institutions[0].display_name | University of Lucerne |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Gisela Michel |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Faculty of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland. |
| authorships[5].author.id | https://openalex.org/A5036799502 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Vesna Pavasovic |
| authorships[5].countries | GB |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I2800129641, https://openalex.org/I45129253 |
| authorships[5].affiliations[0].raw_affiliation_string | Department of Paediatric Haematology and Oncology, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom. |
| authorships[5].institutions[0].id | https://openalex.org/I2800129641 |
| authorships[5].institutions[0].ror | https://ror.org/00zn2c847 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I2800129641, https://openalex.org/I2800349819 |
| authorships[5].institutions[0].country_code | GB |
| authorships[5].institutions[0].display_name | Great Ormond Street Hospital |
| authorships[5].institutions[1].id | https://openalex.org/I45129253 |
| authorships[5].institutions[1].ror | https://ror.org/02jx3x895 |
| authorships[5].institutions[1].type | education |
| authorships[5].institutions[1].lineage | https://openalex.org/I124357947, https://openalex.org/I45129253 |
| authorships[5].institutions[1].country_code | GB |
| authorships[5].institutions[1].display_name | University College London |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Vesna Pavasovic |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Department of Paediatric Haematology and Oncology, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom. |
| authorships[6].author.id | https://openalex.org/A5017429786 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-3578-7152 |
| authorships[6].author.display_name | Katrin Scheinemann |
| authorships[6].countries | CA, CH |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I161941770, https://openalex.org/I2801880889, https://openalex.org/I98251732 |
| authorships[6].affiliations[0].raw_affiliation_string | Faculty of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland; Division of Hematology-Oncology, Children's Hospital of Eastern Switzerland, St Gallen, Switzerland; Department of Pediatrics, McMaster Children's Hospital and McMaster University, Hamilton, Canada. |
| authorships[6].institutions[0].id | https://openalex.org/I2801880889 |
| authorships[6].institutions[0].ror | https://ror.org/03cegwq60 |
| authorships[6].institutions[0].type | healthcare |
| authorships[6].institutions[0].lineage | https://openalex.org/I2801880889, https://openalex.org/I76442945 |
| authorships[6].institutions[0].country_code | CA |
| authorships[6].institutions[0].display_name | McMaster Children's Hospital |
| authorships[6].institutions[1].id | https://openalex.org/I98251732 |
| authorships[6].institutions[1].ror | https://ror.org/02fa3aq29 |
| authorships[6].institutions[1].type | education |
| authorships[6].institutions[1].lineage | https://openalex.org/I98251732 |
| authorships[6].institutions[1].country_code | CA |
| authorships[6].institutions[1].display_name | McMaster University |
| authorships[6].institutions[2].id | https://openalex.org/I161941770 |
| authorships[6].institutions[2].ror | https://ror.org/00kgrkn83 |
| authorships[6].institutions[2].type | education |
| authorships[6].institutions[2].lineage | https://openalex.org/I161941770 |
| authorships[6].institutions[2].country_code | CH |
| authorships[6].institutions[2].display_name | University of Lucerne |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Katrin Scheinemann |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Faculty of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland; Division of Hematology-Oncology, Children's Hospital of Eastern Switzerland, St Gallen, Switzerland; Department of Pediatrics, McMaster Children's Hospital and McMaster University, Hamilton, Canada. |
| authorships[7].author.id | https://openalex.org/A5113739969 |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Helena JH van der Pal |
| authorships[7].countries | NL |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210127118 |
| authorships[7].affiliations[0].raw_affiliation_string | Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands. |
| authorships[7].institutions[0].id | https://openalex.org/I4210127118 |
| authorships[7].institutions[0].ror | https://ror.org/02aj7yc53 |
| authorships[7].institutions[0].type | healthcare |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210127118 |
| authorships[7].institutions[0].country_code | NL |
| authorships[7].institutions[0].display_name | Princess Máxima Center |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Helena Jh van der Pal |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands. |
| authorships[8].author.id | https://openalex.org/A5039013393 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-4423-0276 |
| authorships[8].author.display_name | Lorna Zadravec Zaletel |
| authorships[8].countries | SI |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I153976015, https://openalex.org/I3019592416 |
| authorships[8].affiliations[0].raw_affiliation_string | Radiotherapy Department, Institute of Oncology Ljubljana, Ljubljana; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia,. |
| authorships[8].institutions[0].id | https://openalex.org/I3019592416 |
| authorships[8].institutions[0].ror | https://ror.org/00y5zsg21 |
| authorships[8].institutions[0].type | facility |
| authorships[8].institutions[0].lineage | https://openalex.org/I3019592416 |
| authorships[8].institutions[0].country_code | SI |
| authorships[8].institutions[0].display_name | Institute of Oncology Ljubljana |
| authorships[8].institutions[1].id | https://openalex.org/I153976015 |
| authorships[8].institutions[1].ror | https://ror.org/05njb9z20 |
| authorships[8].institutions[1].type | education |
| authorships[8].institutions[1].lineage | https://openalex.org/I153976015 |
| authorships[8].institutions[1].country_code | SI |
| authorships[8].institutions[1].display_name | University of Ljubljana |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Lorna Zadravec Zaletel |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Radiotherapy Department, Institute of Oncology Ljubljana, Ljubljana; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia,. |
| authorships[9].author.id | https://openalex.org/A5067929492 |
| authorships[9].author.orcid | https://orcid.org/0000-0001-5803-1166 |
| authorships[9].author.display_name | Ana E. Amariutei |
| authorships[9].affiliations[0].raw_affiliation_string | Youth Cancer Europe, Cluj-Napoca, Romania. |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Ana E Amariutei |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Youth Cancer Europe, Cluj-Napoca, Romania. |
| authorships[10].author.id | https://openalex.org/A5018512393 |
| authorships[10].author.orcid | https://orcid.org/0000-0002-1162-675X |
| authorships[10].author.display_name | Roderick Skinner |
| authorships[10].countries | GB |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I2800516725, https://openalex.org/I4210138797, https://openalex.org/I84884186 |
| authorships[10].affiliations[0].raw_affiliation_string | Department of Paediatric and Adolescent Haematology and Oncology, Great North Children's Hospital, Royal Victoria Infirmary; Translational and Clinical Research Institute, and Centre for Cancer, Newcastle University, Newcastle upon Tyne, United [email protected]. |
| authorships[10].institutions[0].id | https://openalex.org/I4210138797 |
| authorships[10].institutions[0].ror | https://ror.org/0483p1w82 |
| authorships[10].institutions[0].type | healthcare |
| authorships[10].institutions[0].lineage | https://openalex.org/I2801663869, https://openalex.org/I4210138797 |
| authorships[10].institutions[0].country_code | GB |
| authorships[10].institutions[0].display_name | Great North Children's Hospital |
| authorships[10].institutions[1].id | https://openalex.org/I84884186 |
| authorships[10].institutions[1].ror | https://ror.org/01kj2bm70 |
| authorships[10].institutions[1].type | education |
| authorships[10].institutions[1].lineage | https://openalex.org/I84884186 |
| authorships[10].institutions[1].country_code | GB |
| authorships[10].institutions[1].display_name | Newcastle University |
| authorships[10].institutions[2].id | https://openalex.org/I2800516725 |
| authorships[10].institutions[2].ror | https://ror.org/01p19k166 |
| authorships[10].institutions[2].type | healthcare |
| authorships[10].institutions[2].lineage | https://openalex.org/I2800516725, https://openalex.org/I2801663869 |
| authorships[10].institutions[2].country_code | GB |
| authorships[10].institutions[2].display_name | Royal Victoria Infirmary |
| authorships[10].author_position | last |
| authorships[10].raw_author_name | Roderick Skinner |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Department of Paediatric and Adolescent Haematology and Oncology, Great North Children's Hospital, Royal Victoria Infirmary; Translational and Clinical Research Institute, and Centre for Cancer, Newcastle University, Newcastle upon Tyne, United [email protected]. |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.5644/ama2006-124.438 |
| open_access.oa_status | diamond |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Late Adverse Effects after Treatment for Childhood Acute Leukemia |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11141 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9998999834060669 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2735 |
| primary_topic.subfield.display_name | Pediatrics, Perinatology and Child Health |
| primary_topic.display_name | Childhood Cancer Survivors' Quality of Life |
| related_works | https://openalex.org/W2160554962, https://openalex.org/W2809246414, https://openalex.org/W4387676337, https://openalex.org/W2413304296, https://openalex.org/W2558121798, https://openalex.org/W2080595199, https://openalex.org/W1554565168, https://openalex.org/W2531392656, https://openalex.org/W2965345918, https://openalex.org/W2382326116 |
| cited_by_count | 7 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 7 |
| locations_count | 5 |
| best_oa_location.id | doi:10.5644/ama2006-124.438 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210201824 |
| best_oa_location.source.issn | 1840-1848, 1840-2879 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1840-1848 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Acta Medica Academica |
| best_oa_location.source.host_organization | https://openalex.org/P4310321207 |
| best_oa_location.source.host_organization_name | Academy of Sciences and Arts of Bosnia and Herzegovina |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310321207 |
| best_oa_location.source.host_organization_lineage_names | Academy of Sciences and Arts of Bosnia and Herzegovina |
| best_oa_location.license | cc-by-nc |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Acta Medica Academica |
| best_oa_location.landing_page_url | https://doi.org/10.5644/ama2006-124.438 |
| primary_location.id | doi:10.5644/ama2006-124.438 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210201824 |
| primary_location.source.issn | 1840-1848, 1840-2879 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1840-1848 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Acta Medica Academica |
| primary_location.source.host_organization | https://openalex.org/P4310321207 |
| primary_location.source.host_organization_name | Academy of Sciences and Arts of Bosnia and Herzegovina |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310321207 |
| primary_location.source.host_organization_lineage_names | Academy of Sciences and Arts of Bosnia and Herzegovina |
| primary_location.license | cc-by-nc |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Acta Medica Academica |
| primary_location.landing_page_url | https://doi.org/10.5644/ama2006-124.438 |
| publication_date | 2024-04-15 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W2128975535, https://openalex.org/W2323716083, https://openalex.org/W1965249571, https://openalex.org/W3095917792, https://openalex.org/W3127104364, https://openalex.org/W2805254636, https://openalex.org/W2482801690, https://openalex.org/W2064478335, https://openalex.org/W4214825610, https://openalex.org/W2981743657, https://openalex.org/W2400588048, https://openalex.org/W2418120401, https://openalex.org/W3155409941, https://openalex.org/W2584761797, https://openalex.org/W2807313168, https://openalex.org/W2099144993, https://openalex.org/W1995575367, https://openalex.org/W2792239284, https://openalex.org/W2990311542, https://openalex.org/W2752414510, https://openalex.org/W1982274214, https://openalex.org/W3005639301, https://openalex.org/W3089288901, https://openalex.org/W2025780824, https://openalex.org/W1935834387, https://openalex.org/W1777597016, https://openalex.org/W3190876990, https://openalex.org/W2968907655, https://openalex.org/W2257516528, https://openalex.org/W2885075597, https://openalex.org/W2009708076, https://openalex.org/W2956916713, https://openalex.org/W3153523583, https://openalex.org/W2585303145, https://openalex.org/W2136565061, https://openalex.org/W1992876563, https://openalex.org/W2913936793, https://openalex.org/W2083063948, https://openalex.org/W2944332773, https://openalex.org/W2171824915, https://openalex.org/W2133082414, https://openalex.org/W2128591303, https://openalex.org/W2732089561, https://openalex.org/W2066213242, https://openalex.org/W2806839780, https://openalex.org/W2108771604, https://openalex.org/W2066617715, https://openalex.org/W3123353587, https://openalex.org/W3122334843, https://openalex.org/W2618696300, https://openalex.org/W2900948201, https://openalex.org/W2155568574, https://openalex.org/W3038219074, https://openalex.org/W2946192895, https://openalex.org/W2116819794, https://openalex.org/W1959093538, https://openalex.org/W2263741814, https://openalex.org/W2888098589, https://openalex.org/W3045454960, https://openalex.org/W2918070193, https://openalex.org/W2504712298, https://openalex.org/W1978359045, https://openalex.org/W2047775639, https://openalex.org/W3118634880, https://openalex.org/W3094798079, https://openalex.org/W2298001371, https://openalex.org/W2784355724, https://openalex.org/W1839076539, https://openalex.org/W1561447687, https://openalex.org/W2801843246, https://openalex.org/W2782758263, https://openalex.org/W2086797728, https://openalex.org/W2800139868, https://openalex.org/W2049537158, https://openalex.org/W2162584451, https://openalex.org/W3189335553, https://openalex.org/W3013085740, https://openalex.org/W2905828727, https://openalex.org/W2606398564, https://openalex.org/W2331530689, https://openalex.org/W2080196509, https://openalex.org/W2142732613, https://openalex.org/W2295232816 |
| referenced_works_count | 83 |
| abstract_inverted_index.It | 206 |
| abstract_inverted_index.We | 85 |
| abstract_inverted_index.as | 173 |
| abstract_inverted_index.at | 60 |
| abstract_inverted_index.by | 66 |
| abstract_inverted_index.in | 20, 76, 104, 143 |
| abstract_inverted_index.is | 5, 150, 189, 207 |
| abstract_inverted_index.of | 2, 22, 30, 53, 95, 140, 145, 182, 186, 195, 202, 212, 217, 220 |
| abstract_inverted_index.or | 74 |
| abstract_inverted_index.to | 6, 81, 157, 209, 237 |
| abstract_inverted_index.20% | 52 |
| abstract_inverted_index.60% | 39 |
| abstract_inverted_index.90% | 29 |
| abstract_inverted_index.ALL | 54 |
| abstract_inverted_index.AML | 57 |
| abstract_inverted_index.The | 0, 137, 184 |
| abstract_inverted_index.aim | 1 |
| abstract_inverted_index.and | 9, 14, 37, 55, 79, 92, 99, 115, 119, 125, 134, 169, 180, 215, 229 |
| abstract_inverted_index.are | 45, 72, 161, 235 |
| abstract_inverted_index.one | 62 |
| abstract_inverted_index.the | 87, 96, 155, 174, 192, 213 |
| abstract_inverted_index.use | 194 |
| abstract_inverted_index.With | 25 |
| abstract_inverted_index.bone | 122 |
| abstract_inverted_index.care | 160, 170 |
| abstract_inverted_index.cell | 148 |
| abstract_inverted_index.have | 59 |
| abstract_inverted_index.late | 17, 101, 130, 135, 141, 218 |
| abstract_inverted_index.most | 56, 97 |
| abstract_inverted_index.over | 28, 38 |
| abstract_inverted_index.some | 77 |
| abstract_inverted_index.stem | 147 |
| abstract_inverted_index.such | 172 |
| abstract_inverted_index.that | 51 |
| abstract_inverted_index.this | 3 |
| abstract_inverted_index.wide | 138 |
| abstract_inverted_index.with | 32, 40, 199 |
| abstract_inverted_index.(ALL) | 36 |
| abstract_inverted_index.(AML) | 44 |
| abstract_inverted_index.20-25 | 67 |
| abstract_inverted_index.Large | 47 |
| abstract_inverted_index.These | 71 |
| abstract_inverted_index.about | 16 |
| abstract_inverted_index.acute | 33, 41 |
| abstract_inverted_index.after | 69 |
| abstract_inverted_index.among | 11, 224 |
| abstract_inverted_index.care. | 183, 240 |
| abstract_inverted_index.drugs | 198 |
| abstract_inverted_index.given | 191 |
| abstract_inverted_index.least | 61 |
| abstract_inverted_index.novel | 196 |
| abstract_inverted_index.plans | 171 |
| abstract_inverted_index.raise | 7, 210 |
| abstract_inverted_index.range | 139 |
| abstract_inverted_index.vital | 208 |
| abstract_inverted_index.years | 68 |
| abstract_inverted_index.Recent | 152 |
| abstract_inverted_index.ageing | 133 |
| abstract_inverted_index.cohort | 48 |
| abstract_inverted_index.cured. | 46 |
| abstract_inverted_index.growth | 120 |
| abstract_inverted_index.health | 64, 227 |
| abstract_inverted_index.models | 181 |
| abstract_inverted_index.review | 4 |
| abstract_inverted_index.severe | 100 |
| abstract_inverted_index.adverse | 18, 102 |
| abstract_inverted_index.causes, | 89 |
| abstract_inverted_index.central | 124 |
| abstract_inverted_index.chronic | 63 |
| abstract_inverted_index.effects | 19, 103, 142, 219 |
| abstract_inverted_index.history | 94 |
| abstract_inverted_index.limited | 200 |
| abstract_inverted_index.myeloid | 42 |
| abstract_inverted_index.natural | 93 |
| abstract_inverted_index.ongoing | 187 |
| abstract_inverted_index.studies | 49 |
| abstract_inverted_index.therapy | 223 |
| abstract_inverted_index.Passport | 176 |
| abstract_inverted_index.Survivor | 175 |
| abstract_inverted_index.approach | 156 |
| abstract_inverted_index.children | 31 |
| abstract_inverted_index.clinical | 90 |
| abstract_inverted_index.describe | 86 |
| abstract_inverted_index.effects, | 131 |
| abstract_inverted_index.frequent | 98 |
| abstract_inverted_index.impaired | 116 |
| abstract_inverted_index.leukemia | 35, 43, 106, 222 |
| abstract_inverted_index.parents, | 225 |
| abstract_inverted_index.severity | 216 |
| abstract_inverted_index.stressed | 190 |
| abstract_inverted_index.targeted | 197 |
| abstract_inverted_index.awareness | 8, 211 |
| abstract_inverted_index.childhood | 23, 105, 221 |
| abstract_inverted_index.condition | 65 |
| abstract_inverted_index.existence | 214 |
| abstract_inverted_index.features, | 91 |
| abstract_inverted_index.follow-up | 239 |
| abstract_inverted_index.including | 108, 163 |
| abstract_inverted_index.increased | 82 |
| abstract_inverted_index.informing | 154 |
| abstract_inverted_index.knowledge | 10 |
| abstract_inverted_index.leukemia. | 24 |
| abstract_inverted_index.long-term | 158, 203, 232 |
| abstract_inverted_index.malignant | 110 |
| abstract_inverted_index.metabolic | 112 |
| abstract_inverted_index.necessary | 236 |
| abstract_inverted_index.outcomes. | 204 |
| abstract_inverted_index.patients, | 226 |
| abstract_inverted_index.premature | 83 |
| abstract_inverted_index.summaries | 168 |
| abstract_inverted_index.survivors | 21, 58, 78, 144 |
| abstract_inverted_index.toxicity, | 113, 123 |
| abstract_inverted_index.treatment | 167 |
| abstract_inverted_index.vigilance | 188 |
| abstract_inverted_index.(SurPass), | 177 |
| abstract_inverted_index.Structured | 231 |
| abstract_inverted_index.contribute | 80 |
| abstract_inverted_index.diagnosis. | 70 |
| abstract_inverted_index.discussed, | 162 |
| abstract_inverted_index.electronic | 164 |
| abstract_inverted_index.experience | 201 |
| abstract_inverted_index.fertility, | 117 |
| abstract_inverted_index.frequency, | 88 |
| abstract_inverted_index.guidelines | 179 |
| abstract_inverted_index.healthcare | 12 |
| abstract_inverted_index.importance | 185 |
| abstract_inverted_index.increasing | 193 |
| abstract_inverted_index.mortality. | 84, 136 |
| abstract_inverted_index.neoplasms, | 111 |
| abstract_inverted_index.peripheral | 126 |
| abstract_inverted_index.subsequent | 109 |
| abstract_inverted_index.survivors, | 107 |
| abstract_inverted_index.transplant | 149 |
| abstract_inverted_index.treatment, | 27 |
| abstract_inverted_index.Conclusion. | 205 |
| abstract_inverted_index.accelerated | 132 |
| abstract_inverted_index.demonstrate | 50 |
| abstract_inverted_index.standardize | 238 |
| abstract_inverted_index.threatening | 75 |
| abstract_inverted_index.contemporary | 26 |
| abstract_inverted_index.developments | 153 |
| abstract_inverted_index.haemopoietic | 146 |
| abstract_inverted_index.highlighted. | 151 |
| abstract_inverted_index.personalized | 165 |
| abstract_inverted_index.policymakers | 15 |
| abstract_inverted_index.psychosocial | 129 |
| abstract_inverted_index.surveillance | 178, 233 |
| abstract_inverted_index.survivorship | 159 |
| abstract_inverted_index.disturbances, | 121 |
| abstract_inverted_index.life-changing | 73 |
| abstract_inverted_index.lymphoblastic | 34 |
| abstract_inverted_index.policymakers. | 230 |
| abstract_inverted_index.professionals | 13 |
| abstract_inverted_index.endocrinopathy | 118 |
| abstract_inverted_index.gonadotoxicity | 114 |
| abstract_inverted_index.neurotoxicity, | 127 |
| abstract_inverted_index.professionals, | 228 |
| abstract_inverted_index.cardiotoxicity, | 128 |
| abstract_inverted_index.recommendations | 234 |
| abstract_inverted_index.patient-specific | 166 |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 98 |
| countries_distinct_count | 9 |
| institutions_distinct_count | 11 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8600000143051147 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.97954326 |
| citation_normalized_percentile.is_in_top_1_percent | True |
| citation_normalized_percentile.is_in_top_10_percent | True |